Admission to neonatal special care unit or intensive care unit · opioid‐exposed newborn infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of neonatal intensive or special care unit stay ‐ not reported · opioid‐exposed newborn infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Failure to establish breastfeeding prior to hospital discharge ‐ not reported · opioid‐exposed newborn infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurodevelopmental outcomes beyond infancy ‐ not reported · opioid‐exposed newborn infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Receipt of endotracheal intubation ‐ not reported · opioid‐exposed newborn infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Receipt of assisted ventilation ‐ not reported · opioid‐exposed newborn infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severe visual impairment or blindness at 6 to 12 months' corrected age · Prevention of retinopathy of prematurity in preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rescue treatment with anti‐VEGF agents · Prevention of retinopathy of prematurity in preterm infants
Systemic administration of beta‐blockers may leads to lower rescue treatment with anti‐VEGF agents compared with placebo or no treatment (low certainty).
1 finding from 1 review
Treatment with laser photocoagulation or cryotherapy · Prevention of retinopathy of prematurity in preterm infants
Systemic administration of beta‐blockers may leads to lower treatment with laser photocoagulation or cryotherapy compared with placebo or no treatment (low certainty).
1 finding from 1 review
Progression to stage 2 with plus disease · Prevention of retinopathy of prematurity in preterm infants
Systemic administration of beta‐blockers showed no clear difference in progression to stage 2 with plus disease compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Progression to stage 3 ROP · Prevention of retinopathy of prematurity in preterm infants
Systemic administration of beta‐blockers probably leads to lower progression to stage 3 ROP compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Progression to stage 4 or 5 ROP · Prevention of retinopathy of prematurity in preterm infants
Systemic administration of beta‐blockers showed no clear difference in progression to stage 4 or 5 ROP compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Arterial hypotension and/or bradycardia requiring treatment · Prevention of retinopathy of prematurity in preterm infants
Systemic administration of beta‐blockers may leads to higher arterial hypotension and/or bradycardia requiring treatment compared with placebo or no treatment (low certainty).
1 finding from 1 review
Gestational age (preterm birth < 37 weeks) · preterm infants
Probiotics administered to pregnant women at risk of preterm birth showed no clear difference in preterm birth < 37 weeks' gestation compared with placebo or no intervention (low certainty).
1 finding from 1 review
Culture‐proven sepsis with supplemented probiotic · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Necrotising enterocolitis · preterm infants
Probiotics administered exclusively after birth in mothers of… showed no clear difference in any necrotizing Enterocolitis (NEC) compared with maternal placebo or no intervention (low certainty).
1 finding from 1 review
Mortality before hospital discharge · preterm infants
Probiotics administered exclusively after birth in mothers of… showed no clear difference in death prior to hospital discharge compared with maternal placebo or no intervention (low certainty).
1 finding from 1 review
Death or NEC · preterm infants
Probiotics administered exclusively after birth in mothers of… showed no clear difference in death or NEC compared with maternal placebo or no intervention (low certainty).
1 finding from 1 review
NEC‐related surgery during study period · preterm infants
Probiotics administered exclusively after birth in mothers of… showed no clear difference in surgery for NEC compared with maternal placebo or no intervention (low certainty).
1 finding from 1 review
Neonatal sepsis · preterm infants
Probiotics administered exclusively after birth in mothers of… showed no clear difference in neonatal sepsis compared with maternal placebo or no intervention (low certainty).
1 finding from 1 review